Liver Transplantation in Primary Sclerosing Cholangitis

 

 Buy Article Permissions and Reprints

ABSTRACT

Primary sclerosing cholangitis (PSC) represents an important indication for liver transplantation. Selection for and timing of liver transplantation is difficult due to the disease course and the frequent occurrence of hepatobiliary malignancies. Pretransplantation screening of malignancies is difficult, but brush cytology of the biliary ducts seems to represent a possibility for early detection of some cholangiocarcinomas. Patient and graft survivals following liver transplantation are good, with 1 year patient survival exceeding 90%. Survival is also satisfactory in patients with early detected or highly limited cholangiocarcinomas. Recurrent PSC represents a particular problem, and affects as many as 20 to 40% in a long-term perspective. Few predictors of recurrent disease have been identified; severe rejections and their treatment may be of importance.

REFERENCES

• 1 Adam R, McMaster P, O'Grady J G et al.. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry.  Liver Transpl. 2003;  9 1231-1243
  CrossrefPubMedGoogle Scholar
• 2 Nordic Liver Transplant Registry .Annual report 2004. http://Available at: www.scandiatransplant.org Accessed August 1, 2005
  Google Scholar
• 3 Stieber A C, Marino I R, Iwatsuki S, Starzl T E. Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation.  Int Surg. 1989;  74 1-3
  PubMedGoogle Scholar
• 4 The Organ Procurement and Transplantation Network .http://Available at: www.OPTN.org/latestData/rptData.asp Accessed December 31, 2004
• 5 Brandsaeter B, Broome U, Isoniemi H et al.. Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list.  Liver Transpl. 2003;  9 961-969
  CrossrefPubMedGoogle Scholar
• 6 Brandsaeter B, Friman S, Broomè U et al.. Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries.  Scand J Gastroenterol. 2003;  38 1176-1183
  CrossrefPubMedGoogle Scholar
• 7 Boberg K M, Rocca G, Egeland T et al.. Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis.  Hepatology. 2002;  35 652-657
  CrossrefPubMedGoogle Scholar
• 8 Kim W R, Poterucha J J, Wiesner R H et al.. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.  Hepatology. 1999;  29 1643-1648
  CrossrefPubMedGoogle Scholar
• 9 Ricci P, Therneau T M, Malinchoc M et al.. A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease.  Hepatology. 1997;  25(3) 672-677
  CrossrefPubMedGoogle Scholar
• 10 Fausa O, Schrumpf E, Elgjo K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis.  Semin Liver Dis. 1991;  11 31-39
  Article in Thieme ConnectPubMedGoogle Scholar
• 11 Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M, Ricci G. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group.  Eur J Gastroenterol Hepatol. 1996;  8 685-691
  PubMedGoogle Scholar
• 12 Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan-analysis of 192 cases.  J Gastroenterol. 1997;  32 134-137
  CrossrefPubMedGoogle Scholar
• 13 Vera A, Moledina S, Gunson B et al.. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft.  Lancet. 2002;  360 1943-1944
  CrossrefPubMedGoogle Scholar
• 14 Vera A, Gunson B K, Ussatoff V et al.. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.  Transplantation. 2003;  75 1983-1988
  CrossrefPubMedGoogle Scholar
• 15 Brandsaeter B, Isoniemi H, Broome U et al.. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy.  J Hepatol. 2004;  40 815-822
  CrossrefPubMedGoogle Scholar
• 16 Bergquist A, Ekbom A, Olsson R et al.. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.  J Hepatol. 2002;  36 321-327
  CrossrefPubMedGoogle Scholar
• 17 Leidenius M, Hockerstedt K, Broome U et al.. Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study.  J Hepatol. 2001;  34 792-798
  CrossrefPubMedGoogle Scholar
• 18 Buckles D C, Lindor K D, LaRusso N F, Petrovic L M, Gores G J. In primary sclerosing cholangitis, gallbladder polyps are frequently malignant.  Am J Gastroenterol. 2002;  97 1138-1142
  CrossrefPubMedGoogle Scholar
• 19 Mazzaferro V, Regalia E, Doci R et al.. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.  N Engl J Med. 1996;  334 693-699
  CrossrefPubMedGoogle Scholar
• 20 Bruix J, Sherman M, Llovet J M et al.. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.  J Hepatol. 2001;  35 421-430
  CrossrefPubMedGoogle Scholar
• 21 Frezza E E, Mezghebe H. Gallbladder carcinoma: a 28 year experience.  Int Surg. 1997;  82 295-300
  PubMedGoogle Scholar
• 22 Ahrendt S A, Pitt H A, Nakeeb A et al.. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.  J Gastrointest Surg. 1999;  3 357-367
  CrossrefPubMedGoogle Scholar
• 23 Campbell W L, Ferris J V, Holbert B L, Thaete F L, Baron R L. Biliary tract carcinoma complicating primary sclerosing cholangitis: evaluation with CT, cholangiography, US, and MR imaging.  Radiology. 1998;  207 41-50
  PubMedGoogle Scholar
• 24 Patt C HM, Thuluvath P JM. Liver transplantation for primary sclerosing cholangitis: screening for biliary malignancy and the role of preemptive transplantation.  Curr Opin Organ Transplant. 2002;  7 129-136
  PubMedGoogle Scholar
• 25 Layfield L J, Cramer H. Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases.  Diagn Cytopathol. 2005;  32 119-124
  CrossrefPubMedGoogle Scholar
• 26 Brandsaeter B, Isoniemi H, Broome U et al.. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy.  J Hepatol. 2004;  40 815-822
  CrossrefPubMedGoogle Scholar
• 27 De Vreede I, Steers J L, Burch P A et al.. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma.  Liver Transpl. 2000;  6 309-316
  CrossrefPubMedGoogle Scholar
• 28 Sudan D, DeRoover A, Chinnakotla S et al.. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma.  Am J Transplant. 2002;  2 774-779
  CrossrefPubMedGoogle Scholar
• 29 Meyer C G, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients.  Transplantation. 2000;  69 1633-1637
  PubMedGoogle Scholar
• 30 Wiesner R H, Porayko M K, Dickson E R et al.. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis.  Hepatology. 1992;  16 1290-1299
  CrossrefPubMedGoogle Scholar
• 31 Welsh F K, Wigmore S J. Roux-en-Y choledochojejunostomy is the method of choice for biliary reconstruction in liver transplantation for primary sclerosing cholangitis.  Transplantation. 2004;  77 602-604
  PubMedGoogle Scholar
• 32 Olsson R, Bjornsson E, Backman L et al.. Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers.  J Hepatol. 1998;  28 426-432
  CrossrefPubMedGoogle Scholar
• 33 Wiesner R H. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease.  Best Pract Res Clin Gastroenterol. 2001;  15 667-680
  CrossrefPubMedGoogle Scholar
• 34 Tzakis A G, Gordon R D, Shaw Jr B W, Iwatsuki S, Starzl T E. Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era.  Transplantation. 1985;  40 667-671
  CrossrefPubMedGoogle Scholar
• 35 Merion R M, Burtch G D, Ham J M, Turcotte J G, Campbell D A. The hepatic artery in liver transplantation.  Transplantation. 1989;  48 438-443
  CrossrefPubMedGoogle Scholar
• 36 Goldstein R M, Secrest C L, Klintmalm G B, Husberg B S. Problematic vascular reconstruction in liver transplantation. Part I Arterial.  Surgery. 1990;  107 540-543
  PubMedGoogle Scholar
• 37 Neuberger J. Incidence, timing, and risk factors for acute and chronic rejection.  Liver Transpl Surg. 1999;  5(suppl 1) 30-36
  PubMedGoogle Scholar
• 38 Lerut J, Demetris A J, Stieber A C et al.. Intrahepatic bile duct strictures after human orthotopic liver transplantation. Recurrence of primary sclerosing cholangitis or unusual presentation of allograft rejection?.  Transpl Int. 1988;  1 127-130
  CrossrefPubMedGoogle Scholar
• 39 Porayko M K, Kondo M, Steers J L. Liver transplantation: late complications of the biliary tract and their management.  Semin Liver Dis. 1995;  15 139-155
  PubMedGoogle Scholar
• 40 Feller R B, Waugh R C, Selby W S, Dolan P M, Sheil A G, McCaughan G W. Biliary strictures after liver transplantation: clinical picture, correlates and outcomes.  J Gastroenterol Hepatol. 1996;  11 21-25
  PubMedGoogle Scholar
• 41 Neuberger J. Liver transplantation for cholestatic liver disease.  Curr Treat Options Gastroenterol. 2003;  6 113-121
  PubMedGoogle Scholar
• 42 Graziadei I W, Wiesner R H, Batts K P et al.. Recurrence of primary sclerosing cholangitis following liver transplantation.  Hepatology. 1999;  29 1050-1056
  CrossrefPubMedGoogle Scholar
• 43 Harrison R F, Davies M H, Neuberger J M, Hubscher S G. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis?.  Hepatology. 1994;  20 356-361
  CrossrefPubMedGoogle Scholar
• 44 Jeyarajah D R, Netto G J, Lee S P et al.. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?.  Transplantation. 1998;  66 1300-1306
  PubMedGoogle Scholar
• 45 Khettry U, Keaveny A, Goldar-Najafi A et al.. Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study.  Hum Pathol. 2003;  34 1127-1136
  CrossrefPubMedGoogle Scholar
• 46 Kubota T, Thomson A, Clouston A D et al.. Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantation.  J Hepatobiliary Pancreat Surg. 1999;  6 377-381
  CrossrefPubMedGoogle Scholar
• 47 Kugelmas M, Spiegelman P, Osgood M J et al.. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.  Liver Transpl. 2003;  9 727-732
  CrossrefPubMedGoogle Scholar
• 48 Liden H, Norrby J, Friman S, Olausson M. Liver transplantation for primary sclerosing cholangitis-a single-center experience.  Transpl Int. 2000;  13(S1) 62-64
  PubMedGoogle Scholar
• 49 MacLean A R, Lilly L, Cohen Z, O'Connor B, McLeod R S. Outcome of patients undergoing liver transplantation for primary sclerosing cholangitis.  Dis Colon Rectum. 2003;  46 1124-1128
  CrossrefPubMedGoogle Scholar
• 50 Narumi S, Roberts J P, Emond J C, Lake J, Ascher N L. Liver transplantation for sclerosing cholangitis.  Hepatology. 1995;  22 451-457
  CrossrefPubMedGoogle Scholar
• 51 Sheng R, Campbell W L, Zajko A B, Baron R L. Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence of recurrent disease.  AJR Am J Roentgenol. 1996;  166 1109-1113
  PubMedGoogle Scholar
• 52 Yusoff I F, House A K, De Boer W B et al.. Disease recurrence after liver transplantation in Western Australia.  J Gastroenterol Hepatol. 2002;  17 203-207
  CrossrefPubMedGoogle Scholar
• 53 Goss J A, Shackleton C R, Farmer D G et al.. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.  Ann Surg. 1997;  225 472-481
  CrossrefPubMedGoogle Scholar
• 54 Brandsaeter B, Schrumpf E, Bentdal O et al.. Recurrent primary sclerosing cholangitis after liver transplantation: A magnetic resonance cholangiography study with analyses of predictive factors.  Liver Transpl. 2005;  11(11) 1361-1369
  CrossrefPubMedGoogle Scholar
• 55 Hiroyuki S, Hironori Y, Kiichi T et al.. Application of double-balloon endoscopy for afferent limb lesions of Roux-en-Y surgical anastomoses.  Gastrointest Endosc. 2005;  61(suppl 5) AB238
  PubMedGoogle Scholar
• 56 Graziadei I W, Wiesner R H, Marotta P J et al.. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.  Hepatology. 1999;  30 1121-1127
  CrossrefPubMedGoogle Scholar
• 57 Papatheodoridis G V, Hamilton M, Mistry P K, Davidson B, Rolles K, Burroughs A K. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.  Gut. 1998;  43 639-644
  PubMedGoogle Scholar
• 58 Dvorchik I, Subotin M, Demetris A J et al.. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis.  Hepatology. 2002;  35 380-384
  CrossrefPubMedGoogle Scholar
• 59 Haagsma E B, Van Den Berg A P, Kleibeuker J H, Slooff M J, Dijkstra G. Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens.  Aliment Pharmacol Ther. 2003;  18 33-44
  CrossrefPubMedGoogle Scholar
• 60 Broome U, Lofberg R, Veress B, Eriksson L S. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.  Hepatology. 1995;  22 1404-1408
  CrossrefPubMedGoogle Scholar

Kristian BjøroM.D. Ph.D. 

Department of Medicine, Rikshospitalet

0027 Oslo, Norway

Email: kristian.bjoro@rikshospitalet.no